Clinical Trial Update: A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ASP5354 to visualize sentinel lymph nodes during surgery in breast cancer or melanoma was terminated. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma

Drugs mentioned

• ASP5354

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Sentinel Lymph Node Biopsy, Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2024-05-01